TAMER Executive and Leadership Team

Fayad AlDandashi, the Chief Executive Officer at TAMER, directs the overarching corporate strategy for the pharmaceutical holding company. AlDandashi manages the integration of import, distribution, and manufacturing operations to ensure market leadership across the Middle East. By aligning departmental goals with the long-term vision of the organization, the Chief Executive Officer drives sustainable growth and operational efficiency. Fayad AlDandashi maintains constant communication with the Board to refine business models and expand the footprint of the company within the competitive healthcare sector. This leadership role involves navigating complex regulatory environments while maintaining high standards of service delivery. Through rigorous oversight of all business units, the Chief Executive Officer ensures that the organization remains at the forefront of the pharmaceutical industry. AlDandashi prioritizes innovation and quality, securing the reputation of the firm as a premier partner for global healthcare brands seeking entry into the Saudi market.

Ibrahim Assiri, the Chief Executive Officer Office Manager at TAMER, coordinates executive workflows and optimizes administrative efficiency for the leadership team. Assiri manages the flow of critical information between the office of the Chief Executive Officer and various operational divisions, ensuring that strategic priorities receive immediate attention. By streamlining internal communication protocols, the Chief Executive Officer Office Manager facilitates rapid decision-making across the pharmaceutical distribution network. Ibrahim Assiri monitors project timelines and resource allocation to support the broader mission of the company. This role requires precise management of executive schedules and high-level correspondence to maintain organizational alignment. Through the implementation of robust administrative systems, the Chief Executive Officer Office Manager enhances the productivity of the senior leadership group. Assiri ensures that all operational activities remain consistent with the corporate governance standards established by the firm, ultimately supporting the seamless execution of business objectives throughout the regional market.

Ayman Barqawi, the Chief Executive Officer - Tamer Logistcics at TAMER, architects the supply chain and distribution infrastructure required for pharmaceutical excellence. Barqawi oversees the complex logistics network that enables the movement of medical products across the region, ensuring compliance with strict safety and quality standards. By optimizing warehouse operations and transportation routes, the Chief Executive Officer - Tamer Logistcics drives efficiency and reduces lead times for critical healthcare supplies. Ayman Barqawi collaborates with other senior leaders to integrate logistics capabilities with the broader marketing and promotion strategies of the company. This leadership role involves managing large-scale distribution assets and implementing advanced tracking technologies to maintain inventory accuracy. Through the continuous improvement of logistics processes, the Chief Executive Officer - Tamer Logistcics supports the expansion of the firm into new territories. Barqawi ensures that the supply chain remains resilient and capable of meeting the evolving demands of the Saudi healthcare market.

Jalil Juha, the Chief Executive Officer Tamer Healthcare at TAMER, leads the specialized division focused on healthcare promotion and clinical service delivery. Juha manages the relationships with healthcare providers and institutions, ensuring that the pharmaceutical portfolio reaches the intended patient populations effectively. By directing the marketing and promotion strategies for medical products, the Chief Executive Officer Tamer Healthcare drives market penetration and brand awareness. Jalil Juha works closely with the manufacturing and distribution teams to align product availability with clinical needs. This leadership role involves analyzing market trends and identifying opportunities for growth within the healthcare sector. Through the strategic management of the healthcare division, the Chief Executive Officer Tamer Healthcare enhances the overall value proposition of the company. Juha ensures that all promotional activities adhere to ethical standards and regulatory requirements, ultimately contributing to the improvement of health outcomes across the region through professional engagement and product expertise.

Khaled Alomari, the Chief Executive Officer, Tamer Services Company at TAMER, directs the specialized service offerings that support the core pharmaceutical business. Alomari manages the delivery of value-added services, including regulatory support, market access, and business development initiatives. By aligning service capabilities with the needs of global partners, the Chief Executive Officer, Tamer Services Company drives client satisfaction and long-term retention. Khaled Alomari coordinates with other divisions to ensure that service delivery remains integrated with the broader distribution and marketing efforts of the firm. This leadership role involves managing cross-functional teams and fostering innovation in service models to address the unique challenges of the healthcare industry. Through the strategic oversight of the services division, the Chief Executive Officer, Tamer Services Company enhances the competitive advantage of the organization. Alomari ensures that all service operations meet the highest quality standards, supporting the overall mission of the company to provide comprehensive healthcare solutions.

Ahmad Awartani CFM CIA CMA, the Chief Financial Officer at TAMER, manages the fiscal health and capital allocation strategies for the organization. Awartani oversees financial reporting, budgeting, and risk management processes to ensure the long-term stability of the pharmaceutical holding company. By implementing rigorous internal controls and auditing procedures, the Chief Financial Officer drives transparency and accountability across all business units. Ahmad Awartani CFM CIA CMA collaborates with the executive team to evaluate investment opportunities and optimize the financial performance of the company. This leadership role involves monitoring cash flow and managing relationships with financial institutions to support ongoing operational needs. Through the application of advanced financial analysis, the Chief Financial Officer provides the insights necessary for informed strategic decision-making. Awartani ensures that the financial structure of the firm remains robust, enabling the company to pursue growth initiatives while maintaining a strong balance sheet in the competitive Saudi market.

Ala Warrad, the Group Chief Financial Officer at TAMER, directs the consolidated financial strategy and capital structure for the entire holding company. Warrad oversees the financial planning and analysis for all subsidiaries, ensuring that the group maintains a cohesive approach to fiscal management. By monitoring group-wide performance metrics, the Group Chief Financial Officer drives profitability and operational efficiency across the diverse business portfolio. Ala Warrad works with the Board and senior leadership to set financial targets and allocate resources to high-growth areas. This leadership role involves managing complex financial reporting requirements and ensuring compliance with international accounting standards. Through the strategic oversight of group finances, the Group Chief Financial Officer provides the stability required for the company to expand its pharmaceutical and healthcare operations. Warrad ensures that the financial health of the group remains a priority, supporting the long-term vision of the firm as a leader in the regional market.

Nessreen Khuja, the Chief Human Resources Officer at TAMER, architects the talent management and organizational development strategies for the company. Khuja oversees recruitment, training, and performance management programs to ensure that the workforce remains aligned with the strategic goals of the pharmaceutical holding company. By fostering a culture of excellence and professional growth, the Chief Human Resources Officer drives employee engagement and retention. Nessreen Khuja collaborates with the executive team to design compensation structures and succession plans that support the long-term stability of the organization. This leadership role involves managing human capital across diverse operational functions, from logistics to healthcare promotion. Through the implementation of modern HR technologies and policies, the Chief Human Resources Officer enhances the operational efficiency of the firm. Khuja ensures that the company attracts and retains top-tier talent, which is essential for maintaining the market position of the firm within the evolving Saudi healthcare landscape.

Mohammad Momani, the Chief Legal Officer at TAMER, architects the legal and compliance framework for the pharmaceutical holding company. Momani oversees all legal matters, including contract negotiations, regulatory compliance, and intellectual property protection. By ensuring that all business activities adhere to local and international laws, the Chief Legal Officer drives risk mitigation and protects the reputation of the firm. Mohammad Momani collaborates with the executive team to navigate the complex regulatory environment of the healthcare industry. This leadership role involves managing external legal counsel and providing guidance on corporate governance matters. Through the proactive management of legal risks, the Chief Legal Officer supports the strategic initiatives of the company and facilitates smooth operations across all divisions. Momani ensures that the organization remains compliant with evolving healthcare regulations, which is critical for maintaining the trust of partners and customers in the competitive Saudi market.